GEN

Enabling RNA Modalities for Therapeutic Innovation: Harnessing Microfluidic Characterization

Dipti Mehta has worked as a Senior Application Scientist at Revvity since 2022. Her research in DNA and protein assay development with LabChip GX Touch technology has generated new commercial assays.
Business Wire

Revvity and Element Biosciences Announce Collaboration to Improve Next Generation Sequencing Research Workflow

WALTHAM, Mass. & SAN DIEGO--(BUSINESS WIRE)--Revvity, Inc. and Element Biosciences, Inc., a developer of the AVITI™ System, an innovative and emerging genomic sequencing platform, today announced a ...
Business Wire

Propelling Diagnostics and Life Sciences Innovation from Early Phase Research to the Clinic: Revvity Showcases Cutting-Edge Solutions at SLAS2024

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. is set to boldly unveil its new branding while showcasing more than 40 products from its life sciences and diagnostics portfolio at SLAS2024 to be held ...
GEN

Simple and Precise pDNA Analytics and Quality Control

Circular double-stranded plasmid DNA (pDNA) plays a crucial role in vaccine development, cell and gene therapy, and recombinant protein or mAb production. These small pieces of DNA carry targeted ...